Management and Optimization of Hemostasis

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Allikas‎: N Engl J Med 2017;376(2):136-48.

Indekseeritud‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (avab uue akna)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (avab uue akna)

Nurözler F, Kutlu T, Küçük G.

Allikas‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Indekseeritud‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (avab uue akna)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (avab uue akna)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Allikas‎: JAMA Surg 2013;148(6):538-47.

Indekseeritud‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (avab uue akna)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (avab uue akna)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Allikas‎: JAMA. 2022;328(4):336-47.

Indekseeritud‎: PubMed 35881121

DOI‎: 10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (avab uue akna)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (avab uue akna)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Allikas‎: Anesth Analg 2012;115(2):239-43.

Indekseeritud‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (avab uue akna)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (avab uue akna)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Allikas‎: Ann Thorac Surg 2010;89(5):1489-95.

Indekseeritud‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (avab uue akna)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (avab uue akna)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Allikas‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Indekseeritud‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (avab uue akna)

Rekombinantne aktiveeritud hüübimisfaktor VII (rFVIIa)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (avab uue akna)

Ballen J, Raabe M, Muirhead B.

Allikas‎: Can J Anaesth 2006;53(4):353-6.

Indekseeritud‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (avab uue akna)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (avab uue akna)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Allikas‎: Transfusion 2013;53(4):798-804.

Indekseeritud‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (avab uue akna)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (avab uue akna)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Allikas‎: Ann Thorac Surg 2008;85(3):836-44.

Indekseeritud‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (avab uue akna)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (avab uue akna)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Allikas‎: Can J Cardiol 2011;27(6):869.e7-8.

Indekseeritud‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (avab uue akna)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (avab uue akna)

Flynn BC, Steiner ME, Mazzeffi M

Allikas‎: Anesthesiology. 2023 1;139(2):197-210.

Indekseeritud‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (avab uue akna)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (avab uue akna)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Allikas‎: Circulation 2009;120(1):21-7.

Indekseeritud‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (avab uue akna)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (avab uue akna)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Allikas‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Indekseeritud‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (avab uue akna)

Off-label use of recombinant human factor VIIa. (avab uue akna)

Goodnough LT, Levy JH.

Allikas‎: Ann Thorac Surg 2014;98(2):393-5.

Indekseeritud‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (avab uue akna)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (avab uue akna)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Allikas‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Indekseeritud‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (avab uue akna)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (avab uue akna)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Allikas‎: Circulation 2008;118(4):331-8.

Indekseeritud‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (avab uue akna)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (avab uue akna)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Allikas‎: J Vasc Surg 2011;53(4):1032-7.

Indekseeritud‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (avab uue akna)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (avab uue akna)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Allikas‎: Transfus Med Hemother 2012;39(2):139-50.

Indekseeritud‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (avab uue akna)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (avab uue akna)

Lehr EJ, Alford TJ, Wang SH.

Allikas‎: Heart Surg Forum 2010;13(5):E275-9.

Indekseeritud‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (avab uue akna)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (avab uue akna)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Allikas‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Indekseeritud‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (avab uue akna)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (avab uue akna)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Allikas‎: Drugs R D 2015;15(2):187-94.

Indekseeritud‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (avab uue akna)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (avab uue akna)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Allikas‎: A A Case Rep 2015;5(1):3-5.

Indekseeritud‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (avab uue akna)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (avab uue akna)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Allikas‎: Anesthesiology 2003;98(6):1513-5.

Indekseeritud‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (avab uue akna)

Recombinant activated factor VII in cardiac surgery: a systematic review. (avab uue akna)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Allikas‎: Ann Thorac Surg 2007;83(2):707-14.

Indekseeritud‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (avab uue akna)

Hüübimisfaktori kontsentraadid

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (avab uue akna)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Allikas‎: Transfusion 2014;54(5):1348-57.

Indekseeritud‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (avab uue akna)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (avab uue akna)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Allikas‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Indekseeritud‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (avab uue akna)

Reducing blood transfusion in aortic surgery: a novel approach. (avab uue akna)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Allikas‎: Ann Thorac Surg 2019;108(5):1369-75.

Indekseeritud‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (avab uue akna)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (avab uue akna)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Allikas‎: Ann Thorac Surg 2009;88(5):1666-8.

Indekseeritud‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (avab uue akna)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (avab uue akna)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Allikas‎: Crit Care 2016;20:5.

Indekseeritud‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (avab uue akna)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (avab uue akna)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Allikas‎: A A Case Rep 2015;4(10):140-2.

Indekseeritud‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (avab uue akna)

State of the art - how I manage coagulopathy in cardiac surgery patients. (avab uue akna)

Davidson S.

Allikas‎: Br J Haematol 2014;164(6):779-89.

Indekseeritud‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (avab uue akna)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (avab uue akna)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Allikas‎: Anesthesiology 2011;115(6):1179-91.

Indekseeritud‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (avab uue akna)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (avab uue akna)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Allikas‎: JAMA Netw Open 2021;4(4):e213936.

Indekseeritud‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (avab uue akna)

Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery: the FARES-II multicenter randomized clinical trial. (avab uue akna)

Karkouti K, Callum JL, Bartoszko J, Tanaka KA, Knaub S, Brar S, Ghadimi K, Rochon A, Mullane D, Couture EJ, Lin Y, Harle C, Zeller M, Tran DTT, Solomon C, Rao V, Law M, Butt AL, Chen EP, Martins MR, Saha T, Shih AW, Vézina MC, Moussa F, Pereira Cezar Zamper R, Syed S, Buyukdere H, Werner S, Grewal D, Wong D, Vandyck KB, Tanzola R, Hughes B, Royer O, Wong S, Levy JH; FARES-II Study Group

Allikas‎: JAMA 2025;333(20):1781-92.

Indekseeritud‎: PubMed 40156829

DOI‎: 10.1001/jama.2025.3501

https://pubmed.ncbi.nlm.nih.gov/40156829/ (avab uue akna)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (avab uue akna)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Allikas‎: Thromb Haemost 2009;102(1):137-44.

Indekseeritud‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (avab uue akna)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (avab uue akna)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Allikas‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Indekseeritud‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (avab uue akna)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (avab uue akna)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Allikas‎: Anesthesiology 2013;118(1):40-50.

Indekseeritud‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (avab uue akna)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (avab uue akna)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Allikas‎: J Am Heart Assoc 2015;4(6):e002066.

Indekseeritud‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (avab uue akna)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (avab uue akna)

Ranucci M, Baryshnikova E.

Allikas‎: Br J Anaesth 2016;116(5):618-23.

Indekseeritud‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (avab uue akna)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (avab uue akna)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Allikas‎: Can J Anaesth 2012;59(3):299-303.

Indekseeritud‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (avab uue akna)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (avab uue akna)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Allikas‎: Ann Thorac Surg 2019;107(4):1275-83.

Indekseeritud‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (avab uue akna)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (avab uue akna)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Allikas‎: Anesth Analg 2007;104(4):763-5.

Indekseeritud‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (avab uue akna)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (avab uue akna)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Allikas‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indekseeritud‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (avab uue akna)

Desmopressiin

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (avab uue akna)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Allikas‎: Anaesthesia 2010;65(7):688-91.

Indekseeritud‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (avab uue akna)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (avab uue akna)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Allikas‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Indekseeritud‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (avab uue akna)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (avab uue akna)

Wademan BH, Galvin SD.

Allikas‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Indekseeritud‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (avab uue akna)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (avab uue akna)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Allikas‎: Anesth Analg 2010;110(3):702-7.

Indekseeritud‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (avab uue akna)

Paiksed hemostaatilised ained

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (avab uue akna)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Allikas‎: Ann Surg 2010;251(2):217-28.

Indekseeritud‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (avab uue akna)

A review of topical hemostatic agents for use in cardiac surgery. (avab uue akna)

Barnard J, Millner R.

Allikas‎: Ann Thorac Surg 2009;88(4):1377-83.

Indekseeritud‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (avab uue akna)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (avab uue akna)

Forcillo J, Perrault LP.

Allikas‎: Transfus Apher Sci 2014;50(1):26-31.

Indekseeritud‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (avab uue akna)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (avab uue akna)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Allikas‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Indekseeritud‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (avab uue akna)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (avab uue akna)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Allikas‎: Innovations (Phila) 2012;7(4):229-41.

Indekseeritud‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (avab uue akna)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (avab uue akna)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Allikas‎: J Card Surg 2009;24(6):722-4.

Indekseeritud‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (avab uue akna)

Topical haemostatic agents. (avab uue akna)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Allikas‎: Br J Surg 2008;95(10):1197-225.

Indekseeritud‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (avab uue akna)

Viskoelastsed testid kirurgilise või koagulopaatilise verejooksu tuvastamiseks

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (avab uue akna)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Allikas‎: Transfus Med 2006;16(1):31-9.

Indekseeritud‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (avab uue akna)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (avab uue akna)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Allikas‎: Anesthesiology 2011;115(6):1179-91.

Indekseeritud‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (avab uue akna)

Management of hemorrhage in cardiothoracic surgery. (avab uue akna)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Allikas‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Indekseeritud‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (avab uue akna)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (avab uue akna)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Allikas‎: Anesthesiology 2012;117(3):531-47.

Indekseeritud‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (avab uue akna)

Antifibrinolüütilised ained

Rekombinantne aktiveeritud hüübimisfaktor VII (rFVIIa)

Hüübimisfaktori kontsentraadid

Desmopressiin

Paiksed hemostaatilised ained

Viskoelastsed testid kirurgilise või koagulopaatilise verejooksu tuvastamiseks

Vali keel